MURA
Price
$4.05
Change
-$0.17 (-4.03%)
Updated
Feb 21 closing price
Capitalization
69.09M
37 days until earnings call
VIR
Price
$9.57
Change
-$0.23 (-2.35%)
Updated
Feb 21 closing price
Capitalization
1.32B
3 days until earnings call
Ad is loading...

MURA vs VIR

Header iconMURA vs VIR Comparison
Open Charts MURA vs VIRBanner chart's image
Mural Oncology
Price$4.05
Change-$0.17 (-4.03%)
Volume$83.44K
Capitalization69.09M
Vir Biotechnology
Price$9.57
Change-$0.23 (-2.35%)
Volume$712.71K
Capitalization1.32B
MURA vs VIR Comparison Chart
Loading...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MURA vs. VIR commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MURA is a Hold and VIR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (MURA: $4.05 vs. VIR: $9.57)
Brand notoriety: MURA and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MURA: 45% vs. VIR: 30%
Market capitalization -- MURA: $69.09M vs. VIR: $1.32B
MURA [@Biotechnology] is valued at $69.09M. VIR’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MURA’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MURA’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MURA’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • MURA’s TA Score: 4 bullish, 5 bearish.
  • VIR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VIR is a better buy in the short-term than MURA.

Price Growth

MURA (@Biotechnology) experienced а -5.59% price change this week, while VIR (@Biotechnology) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

MURA is expected to report earnings on May 20, 2025.

VIR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.32B) has a higher market cap than MURA($69.1M). VIR YTD gains are higher at: 30.381 vs. MURA (25.776). MURA has higher annual earnings (EBITDA): -157.66M vs. VIR (-562.68M). VIR has more cash in the bank: 914M vs. MURA (176M). MURA has less debt than VIR: MURA (9.55M) vs VIR (113M). VIR has higher revenues than MURA: VIR (62M) vs MURA (0).
MURAVIRMURA / VIR
Capitalization69.1M1.32B5%
EBITDA-157.66M-562.68M28%
Gain YTD25.77630.38185%
P/E RatioN/AN/A-
Revenue062M-
Total Cash176M914M19%
Total Debt9.55M113M8%
TECHNICAL ANALYSIS
Technical Analysis
MURAVIR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Ad is loading...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVIAX18.31-0.18
-0.97%
Praxis Value Index A
PKAIX13.81-0.23
-1.64%
PIMCO RAE US Instl
CSXRX51.68-0.98
-1.86%
Calvert US Large Cap Core Rspnb Idx R6
PQJCX14.14-0.37
-2.55%
PGIM Jennison Small-Cap Core Equity R6
RSMRX15.52-0.43
-2.70%
RBC SMID Cap Growth R6

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with STRO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
-4.03%
STRO - MURA
37%
Loosely correlated
-3.28%
MGTX - MURA
37%
Loosely correlated
+6.88%
NUVB - MURA
35%
Loosely correlated
-2.64%
CLDX - MURA
33%
Poorly correlated
-0.58%
VIR - MURA
32%
Poorly correlated
-2.35%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-2.35%
SANA - VIR
61%
Loosely correlated
-1.63%
AXON - VIR
47%
Loosely correlated
-5.28%
GOSS - VIR
41%
Loosely correlated
-8.50%
CPRX - VIR
37%
Loosely correlated
-1.95%
IVVD - VIR
36%
Loosely correlated
+46.28%
More